ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
11 announcements
Chandan Healthcare scaled its diagnostic franchise network to 500+ centres, reaching a total of 568+ centres. It targets 1,000 centres by FY27-end and 3,000 in two years.
Chandan Healthcare clarified to NSE it has one reportable segment, explaining the omission of segment-wise details in its Q4 FY27 financial results.
Chandan Healthcare Limited has allotted 5,99,998 equity shares upon conversion of fully convertible warrants, aggregating to ₹14.04 Crore.
Chandan Healthcare Ltd's board approved the appointment of an Independent Director, ratified cost auditor remuneration, and recommended varying the objects for utilising unutilised warrant proceeds.
Chandan Healthcare is pivoting from pharmacy trading to a high-margin diagnostic-led strategy. The company reported healthy revenue growth but is over-relying on capital-light franchise scaling to drive future profitability.
Chandan Healthcare reported strong Q1 FY27 results with 19.62% YoY revenue growth and 42.27% EBITDA growth, driven by expansion into 15 states and diversified B2C, B2B, and B2G segments.
Chandan Healthcare Ltd reported revenue from operations of ₹80.9 Cr (+19.1% YoY) and net profit of ₹7.5 Cr (+29.3% YoY) for Q1 FY27.
Chandan Healthcare reported strong FY26 performance with Revenue of ₹280.67 Cr and PAT of ₹27.06 Cr, driven by network expansion and strategic PPP projects.
Chandan Healthcare reported robust FY26 results with 20.43% revenue growth, transitioning to a pan-India diagnostic model while scaling franchise and PPP projects.
Chandan Healthcare delivered robust FY26 growth, pivoting from a regional player to a pan-India diagnostic platform. Management remains aggressively optimistic about franchise scaling and government PPP projects despite high capital intensity.
Chandan Healthcare Ltd reported revenue from operations of ₹75.6 Cr (+20.8% YoY) and net profit of ₹6.9 Cr (+15.0% YoY) for Q4 FY26.